Marvel Biosciences Corp (MRVL) — Financial Flexibility Index
Marvel Biosciences Corp (MRVL) has a Financial Flexibility Index of -0.04x as of October 2025. Free cash flow of CA$-178.46K (operating CF CA$-178.46K minus capex CA$0.00) represents 0% of total liabilities (CA$4.33 Million). Check Marvel Biosciences Corp (MRVL) tangible net worth to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Marvel Biosciences Corp Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Marvel Biosciences Corp across 6 annual periods. For the full cash flow conversion analysis, see Marvel Biosciences Corp cash conversion from operations.
Annual Financial Flexibility Index for Marvel Biosciences Corp (2020–2025)
Year-by-year free cash flow to debt coverage for Marvel Biosciences Corp. Explore MRVL operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | CA$-1.15 Million | CA$-1.15 Million | CA$4.33 Million | ▲ +25.3% |
| 2024 | -0.36x | CA$-1.18 Million | CA$-1.18 Million | CA$3.32 Million | ▲ +36.1% |
| 2023 | -0.56x | CA$-1.33 Million | CA$-1.33 Million | CA$2.39 Million | ▲ +81.8% |
| 2022 | -3.06x | CA$-2.19 Million | CA$-2.19 Million | CA$718.00K | ▲ +74.9% |
| 2021 | -12.19x | CA$-1.37 Million | CA$-1.37 Million | CA$112.48K | ▼ -300.9% |
| 2020 | -3.04x | CA$-538.53K | CA$-538.53K | CA$177.18K | — |